Market Research Reports

Drugs of Abuse Testing Market (Sample Based Testing - Urine, Saliva and Hair Onsite and laboratory Testing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

77pages
Published Date: 2014-01-28
 

Description




The global drugs of abuse testing market is rapidly growing due to the rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. Globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse.is also supporting the growth of the drugs of abuse testing market. 

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of XX% during 2013 – 2018. The other major samples for drugs of abuse testing are Saliva and Hair. This report forecasts future potential of all these drugs of abuse testing markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key players.

The report categorizes the global drugs of abuse market based on their type and geography. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only. In the segment of geographic analysis, the report identifies and analyses market sizes and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). North America region covers the scenario of the US. Europe region covers the scenario of France, Germany and the UK. Asia Pacific region highlights the scenario of India, China and Japan.  

Table of Contents




Table of Content

Chapter 1 Preface 8
1.1 Report Description 8
1.2 Markets covered 8
1.3 Research methodology 8

Chapter 2 Executive Summary 10

Chapter 3 Drugs of Abuse Testing Market – Industry Analysis 11
3.1 Introduction 11
      3.1.1 International drug trafficking 12
      3.1.2 Drug trafficking and illicit drug use in North America 12
      3.1.3 Drug trafficking and illicit drug use in Europe 12
      3.1.4 Drug trafficking and illicit drug use in Asia-Pacific 13
3.2 Market Drivers 14
      3.2.1 Globally rising consumption of illicit drugs 14
      3.2.2 Adoption of drugs of abuse (DOA) testing at organizational level 15
      3.2.3 Increased production of illicit drugs and their trade 16
      3.2.4 Increasing death rates/road accidents due to drug abuse 17
3.3 Restraints 18
      3.3.1 Social concerns associated with illicit drugs testing 18
      3.3.2 Legalization of various drugs 18
      3.3.3 Economic volatility and cost concerns 19

Chapter 4 Porter’s five force analysis 20
4.1 Bargaining power of buyers 20
4.2 Bargaining power of suppliers 21
4.3 Threat from new entrants 21
4.4 Intensity of rivalry 21
4.5 Threat from substitutes 21

Chapter 5 Global Drugs of Abuse Testing Market 22

Chapter 6 Drugs of Abuse Testing Market – Testing Technology Analysis 24
6.1 Immunoassay Technology 24
6.2 Chromatography Technology 25

Chapter 7 Drugs of Abuse Testing Market – Sample Analysis 27
7.1 Laboratory drug test 30
7.2 On-site screening test 31

Chapter 8 Single vs. Multiple Parameter Test 33

Chapter 9 Drugs of Abuse Market – Regional Segment Analysis 35
9.1 Scenario of drug testing in North America 35
      9.1.1 Scenario of drug testing in the US 37
9.2 Scenario of drug testing in Europe 39
      9.2.1 Scenario of drug testing in the UK 41
      9.2.2 Scenario of drug testing in France 43
      9.2.3 Scenario of drug testing in Germany 44
9.3 Scenario of drug testing in Asia-Pacific 46
      9.3.1 Scenario of drug testing in India 48
      9.3.2 Scenario of drug testing in China 50
      9.3.3 Scenario of drug testing in Japan 52

Chapter 10 Recent Developments 54

Chapter 11 Company profiles 57
11.1 Roche Diagnostics 57
      11.1.1 Overview 57
      11.1.2 Products & Segments 57
      11.1.3 Financial Performance 58
11.2 Quest Diagnostic 59
      11.2.1 Overview 59
      11.2.2 Products & Segments 59
      11.2.3 Financial Performance 60
11.3 LabCorp (Laboratory Corporation of America) 61
      11.3.1 Overview 61
      11.3.2 Products & Segments 61
      11.3.3 Financial Performance 62
11.4 Alere 63
      11.4.1 Overview 63
      11.4.2 Products and Segments 63
      11.4.3 Financial Performance 64
11.5 Abbott Laboratories 65
      11.5.1 Overview 65
      11.5.2 Products & Segments 65
      11.5.3 Financial Performance 66
11.6 Randox Laboratories 67
      11.6.1 Overview 67
      11.6.2 Products & Segments 67
      11.6.3 Financial Performance 67
11.7 Psychemedics Corporation 68
      11.7.1 Overview 68
      11.7.2 Products & Services 68
      11.7.3 Financial Performance 69
11.8 Bio-Rad Laboratories 70
      11.8.1 Overview 70
      11.8.2 Products & Segmentation 70
      11.8.3 Financial Performance 71
11.9 Sonic Healthcare 72
      11.9.1 Overview 72
      11.9.2 Products & Services 72
      11.9.3 Financial Performance 73
11.10 Thermo Fisher Scientific 74
      11.10.1 Overview 74
      11.10.2 Products & Segments 74
      11.10.3 Financial performance 75

List of Figures 

FIG. 1 Global illicit drug users (in millions) 2009-2011 15
FIG. 2 Porter’s five forces analysis for drugs of abuse testing market 20
FIG. 3 Drug abuse testing market strategic developments (2011-2013) 54
FIG. 4 Company revenues (USD million, 2011-2012) 58
FIG. 5 Company revenues (USD million, 2011 – 2012) 60
FIG. 6 Company revenues (USD million, 2011 – 2012) 62
FIG. 7 Company revenues (USD million, 2011 – 2012) 64
FIG. 8 Company revenues (USD million, 2011 – 2012) 66
FIG. 9 Company revenues (USD million, 2011 – 2012) 69
FIG. 10 Company revenues (USD million, 2011-2012) 71
FIG. 11 Company revenues (USD million, 2011-2012) 73
FIG. 12 Company revenues (USD million, 2011-2012) 75

List of Tables

TABLE 1 Illicit drug users in various parts of the world, by major drugs (% share, 2011) 11
TABLE 2 Drivers for drugs of abuse testing market: Impact analysis 14
TABLE 3 Restraints for drugs of abuse testing market: Impact analysis 18
TABLE 4 Global drugs of abuse testing market size, by geography 2008-2012 (USD million) 22
TABLE 5 Global drugs of abuse testing market size, by geography 2013-2018 (USD million) 22
TABLE 6 Some of the key market players offering drugs testing equipment and products 26
TABLE 7 Characteristics of different specimens for drug testing 28
TABLE 8 Global drugs of abuse testing market, by sample 2008-2012 (USD million) 29
TABLE 9 Global drugs of abuse testing market, by sample 2013-2018 (USD million) 29
TABLE 10 Advantage and disadvantage of laboratory drug screening test 30
TABLE 11 Advantage and disadvantage of on-site drug screening test 31
TABLE 12 Global drugs of abuse testing market, by test location 2008-2012 (USD million) 32
TABLE 13 Global drugs of abuse testing market, by test location 2013-2018 (USD million) 32
TABLE 14 Advantages of multi panel drug test over single paned drug test 33
TABLE 15 North American drugs of abuse testing market, by geography 2008-2012 (USD million) 35
TABLE 16 North American drugs of abuse testing market, by geography 2013-2018 (USD million) 36
TABLE 17 North American drugs of abuse testing market, by test location 2008-2012 (USD million) 36
TABLE 18 North American drugs of abuse testing market, by test location 2013-2018 (USD million) 37
TABLE 19 US drugs of abuse testing market, by test location 2008-2012 (USD million) 38
TABLE 20 US drugs of abuse testing market, by test location 2013-2018 (USD million) 38
TABLE 21 European drugs of abuse testing market, by geography 2008-2012 (USD million) 39
TABLE 22 European drugs of abuse testing market, by geography 2013-2018 (USD million) 40
TABLE 23 European drugs of abuse testing market, by test location 2008-2012 (USD million) 40
TABLE 24 European drugs of abuse testing market, by test location 2013-2018 (USD million) 41
TABLE 25 UK drugs of abuse testing market, by test location 2008-2012 (USD million) 42
TABLE 26 UK drugs of abuse testing market, by test location 2013-2018 (USD million) 42
TABLE 27 France drugs of abuse testing market, by test location 2008-2012 (USD million) 43
TABLE 28 France drugs of abuse testing market, by test location 2013-2018 (USD million) 44
TABLE 29 Germany drugs of abuse testing market, by test location 2008-2012 (USD million) 45
TABLE 30 Germany drugs of abuse testing market, by test location 2013-2018 (USD million) 45
TABLE 31 Asian drugs of abuse testing market, by geography 2008-2012 (USD million) 46
TABLE 32 Asian drugs of abuse testing market, by geography 2013-2018 (USD million) 47
TABLE 33 Asian drugs of abuse testing market, by test location 2008-2012 (USD million) 47
TABLE 34 Asian drugs of abuse testing market, by test location 2013-2018 (USD million) 48
TABLE 35 Indian drugs of abuse testing market, by test location 2008-2012 (USD thousand) 49
TABLE 36 Indian drugs of abuse testing market, by test location 2013-2018 (USD thousand) 49
TABLE 37 China drugs of abuse testing market, by test location 2008-2012 (USD thousand) 51
TABLE 38 China drugs of abuse testing market, by test location 2013-2018 (USD thousand) 51
TABLE 39 Japan drugs of abuse testing market, by test location 2008-2012 (USD million) 52
TABLE 40 Japan drugs of abuse testing market, by test location 2013-2018 (USD million) 53
TABLE 41 Major product launches in drugs of abuse testing market (2011-2013) 54
TABLE 42 Mergers and acquisitions in drugs of abuse testing market (2011-2013) 55
TABLE 43 Partnerships in drugs of abuse testing market (2011-2013) 56

Enquiry Before Buying




Free Market Analysis




Globally, the drugs of abuse testing market is witnessing significant growth due to rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. As a result, this market is expected to grow at a CAGR of about XX% during 2013 – 2018.

Some of the key driving factors for the drugs of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns. 

North America, including the US has the largest drugs of abuse testing market and also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population and cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, including America and European countries, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. In many countries, government rules & regulations are also supporting the growth of drugs of abuse testing market, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market.

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about XX% during 2013 – 2018. The other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and it is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only. 

Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.

global-ophthalmic-drug-market-size-by-geography-2013-2018
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research